logo
Abilify Maintena (aripiprazole) dosing schedule and details

Abilify Maintena (aripiprazole) dosing schedule and details

The dosage of Abilify Maintena (aripiprazole) for schizophrenia and bipolar I disorder is typically 400 milligrams (mg) once per month. Your dosing schedule may vary based on factors that include your symptoms and other medications you may be taking. It is important to take the Abilify Maintena dosage your doctor prescribes.Abilify Maintena is a prescription drug used in adults to treat schizophrenia and bipolar I disorder. The drug comes as a long-acting intramuscular injection administered by a healthcare professional.The active ingredient in Abilify Maintena is aripiprazole. Abilify Maintena belongs to a group of drugs called antipsychotics.This article describes the dosages of Abilify Maintena, as well as its strengths and how it is given.»Read this in-depth overview for more details about Abilify Maintena.Overview of Abilify Maintena dosage Abilify Maintena is a long-acting injection that contains the active drug aripiprazole. If you have not taken Abilify or aripiprazole before, your doctor will likely have you take an equivalent oral dose of the drug for 2 weeks before starting Abilify Maintena. This is to check how well your body tolerates aripiprazole before you receive the long-acting injection.The following information describes dosages commonly used or recommended for Abilify Maintena. Your doctor will determine the best dosage to fit your needs. In some cases, doctors may adjust your dosage from those mentioned here.Keep reading for more dosage details.Abilify Maintena formsAbilify Maintena is available as a powder in single-use syringes and vials. A healthcare professional will mix the powder with sterile water for injection to make an extended-release suspension. They will administer this by intramuscular injection (an injection into a muscle). Extended-release means the medication is released slowly into your bloodstream over time. After you receive an injection of Abilify Maintena, the medication is released into your bloodstream slowly over 1 month.Abilify Maintena strengthsAbilify Maintena comes in two strengths: 300 mg and 400 mg.Dosage of Abilify Maintena for schizophrenia and bipolar I disorderAbilify Maintena is approved to treat schizophrenia and bipolar I disorder in adults. The typical dosage for these conditions is one injection of 400 mg given once per month.Your doctor will typically switch you to Abilify Maintena from your current oral antipsychotic medication. (This may be an oral form of Abilify or aripiprazole or a different oral antipsychotic.) The recommended dosage of Abilify Maintena is the same regardless of what dose of oral antipsychotic you are currently taking.After your first injection of Abilify Maintena, it can take 2 weeks for the medication to reach an effective level in your body. To make sure your condition is well-managed during this time, you should continue taking your current oral antipsychotic for 2 weeks after your first injection of Abilify Maintena.Always follow your prescribing doctor's instructions. Notify them if you experience any side effects that may prevent you from taking your medication.Factors affecting dosageIn some cases, your doctor may prescribe a different dosage of Abilify Maintena. For example, they may prescribe a lower dosage if you:have bothersome side effects with Abilify Maintenahave a genetic factor that affects how well your body can break down Abilify Maintenatake certain other medications that affect how well your body breaks down Abilify MaintenaYour doctor will prescribe the dosage that's right for you.How Abilify Maintena is givenAbilify Maintena is administered by a doctor, nurse, or other healthcare professional. You will typically receive Abilify Maintena in a clinical setting, such as your doctor's office, clinic, or pharmacy. A healthcare professional will administer Abilify Maintena by intramuscular injection into the muscle in your upper arm or buttock. They'll usually give your injection in alternate arms or buttocks each time you receive a dose. This helps prevent injection site reactions that can occur if you have the injection in the same place each time.Abilify Maintena is usually a long-term treatment. If you and your doctor determine that it's safe and effective for your condition, you'll likely take it long term.If you miss an appointment to receive a dose of Abilify Maintena, call your doctor's office right away to reschedule.Common questions about Abilify Maintena dosageBelow are answers to some commonly asked questions about Abilify Maintena's dosage.What is considered a high dose of Abilify Maintena?The usual dose of Abilify Maintena is 400 mg given once per month. Higher doses than this are not recommended.Your doctor may prescribe a lower dose of Abilify Maintena in certain situations, for example, if you take certain other medications. For more information, see the 'Factors affecting dosage' section.How many mL is a 400-mg injection of Abilify Maintena?To give a 400-mg dose of Abilify Maintena, your healthcare professional will inject 2 milliliters (mL) of the prepared drug.If you have other questions about the dose of Abilify Maintena you are prescribed, talk with your doctor.Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him
Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him

Daily Mail​

timean hour ago

  • Daily Mail​

Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him

Philadelphia Phillies pitcher Zack Wheeler has undergone a successful thrombolysis procedure, which removed a blood clot from his upper body on Monday, the team announced. The procedure was performed by Dr. Paul DiMuzio at Thomas Jefferson University Hospital in downtown Philadelphia. Wheeler's timeline to return to the field and treatment for the procedure has yet to be determined.

On the Edge review – gripping study of France's overstretched mental health system
On the Edge review – gripping study of France's overstretched mental health system

The Guardian

timean hour ago

  • The Guardian

On the Edge review – gripping study of France's overstretched mental health system

Within the corridors of a psychiatric ward in Beaujon hospital in Clichy, Paris, tensions run high. Every day, a steady stream of patients pours in, while resources are stretched pitifully thin. Through jagged handheld cinematography, Nicolas Peduzzi's gripping and passionate documentary reflects the facility's breakneck pace. Amid a flurry of frantic calls and rolling stretchers, a calm presence emerges: here comes Dr Jamal Abdel-Kader, the only staff psychiatrist in the building. The camera trails after Abdel-Kader's hurried steps as he splits his day between various departments, from the emergency rooms to the intensive care units. Despite his colossal workload – a result of crumbling infrastructure and lack of government budget – he devotes his full attention to each individual patient. Some are only in their late teens when they attempt self-harm and even suicide. Others have already spent a lifetime trapped in a cycle of addiction and depression. Although their situations vary, the patients' circumstances all point to structural issues in France's treatment of mental health. Abdel-Kader perceives the private struggles of his patients not simply as personal failings, but as symptoms of an indifferent society, in which people have forgotten how to care for one another. Besides medical intervention, his treatment also includes other forms of therapy, including creative sessions where people gather to study Molière and Shakespeare. Abdel-Kader's conversations with colleagues reveal that the loneliness endured by the patients also extends to the overworked physicians, who are undersupported by the state. These moments of introspection at the hospital, expressed in black-and-white snapshots, lend a human touch to spaces that are still painfully stigmatised in the public eye. In contrast to the outside world driven by productivity and prejudice, here is where care and understanding still exist, against all odds. On the Edge is on True Story from 22 August.

CVS insurance policies don't provide opioid coverage, top Delaware court rules
CVS insurance policies don't provide opioid coverage, top Delaware court rules

Reuters

time2 hours ago

  • Reuters

CVS insurance policies don't provide opioid coverage, top Delaware court rules

Aug 18 (Reuters) - CVS Health (CVS.N), opens new tab is not entitled to coverage from insurers, including AIG (AIG.N), opens new tab and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday. The Delaware Supreme Court concluded that governments, hospitals, doctors and benefit plans that sued CVS sought damages for economic losses, not individualized "bodily injury" or "property damage" covered by CVS's general liability policies. It also rejected the argument that CVS' $5 billion nationwide settlement of opioid claims in November 2022 showed that the pharmacy chain and benefits manager had been sued for bodily injury. "The national settlement agreement funds expenses in response to the opioid crisis at-large, but it does not change the fact that the underlying lawsuits do not seek specific damages tied to individualized injuries," Chief Justice Collins Seitz wrote for a unanimous court. CVS said it disagreed with the decision, and that it trains its pharmacists to make the best decisions on patients' behalf and in compliance with the law. AIG, Chubb and their lawyers did not immediately respond to requests for comment. Many insurers have been sued by pharmacy chains, drugmakers and others seeking coverage for opioid-related bills. Chains had long argued they were merely filling doctors' prescriptions, but critics said the large quantities being dispensed and the potential for diversion were red flags. Walgreens (WBA.O), opens new tab and Walmart, opens new tab(WMT.N), opens new tab agreed to pay more than $8 billion in similar settlements. CVS, based in Woonsocket, Rhode Island, had been appealing two Delaware Superior Court decisions denying insurance coverage in more than 2,300 lawsuits, according to Monday's decision. Governments complained about increased spending to treat opioid addiction, hospitals reported strains on their health systems, and third-party payors such as employee benefit funds cited costs of prescription purchases and addiction treatment. The Delaware Supreme Court ruled in Chubb's favor in a similar case involving Rite Aid in 2022. CVS claimed that its own policies offered broader coverage, but the court found the policies "similar in all material respects" to Rite Aid's. The case is In re CVS Opioid Insurance Litigation, Delaware Supreme Court, No. 482.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store